Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/02/2008WO2008050698A2 Agent for prophylaxis or treatment of alcohol dependence or drug dependence
05/02/2008WO2008050673A1 Adhesive skin patch
05/02/2008WO2008050600A1 Therapeutic or preventive agent for intractable disease based on oxidative stress-mediated cell death as molecular background
05/02/2008WO2008050491A1 Film preparation for forming film on skin
05/02/2008WO2008050483A1 Cardiovascular preparation
05/02/2008WO2008050344A2 Treatment of hepatic encephalopathy and liver cirrhosis
05/02/2008WO2008050339A2 Combination of an aminoglycoside antibiotic and a parp inhibitor
05/02/2008WO2008050329A2 Novel sirnas and methods of use thereof
05/02/2008WO2008050207A1 Heterocyclic compounds useful as anabolic agents for livestock animals
05/02/2008WO2008050200A1 Oxadiazole compounds as calcium channel antagonists
05/02/2008WO2008050188A2 Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
05/02/2008WO2008050185A2 Novel polymorphs of perindopril erbumine
05/02/2008WO2008050168A1 New sulfonamide derivatives as bradykinin antagonists
05/02/2008WO2008050167A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
05/02/2008WO2008050140A2 Compounds for treatment of parasitic infection
05/02/2008WO2008050125A1 Compounds and uses thereof
05/02/2008WO2008050117A1 Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators
05/02/2008WO2008050096A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
05/02/2008WO2008050078A1 Pteridine derivatives as polo-like kinase inhibitors useful in the treatment of cancer
05/02/2008WO2008049997A2 Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
05/02/2008WO2008049996A2 Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
05/02/2008WO2008049994A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/02/2008WO2008049984A2 Use of citrulline for treating undernutrition conditions
05/02/2008WO2008049974A2 Peptide vaccine for influenza virus
05/02/2008WO2008049923A1 CRYSTALLINE FORM OF 4-(ß-D-GLUCOPYRANOS-1-YL)-1-METHYL-2-[4-((S)-TETRAHYDROFURAN-3-YLOXY)-BENZYL]-BENZENE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
05/02/2008WO2008049904A2 Use of mtki 1 for treating or preventing bone cancer
05/02/2008WO2008049901A1 Use of a mt kinase inhibitor for treating or preventing brain cancer
05/02/2008WO2008049875A1 Novel substituted piperidyl-propane-thiols
05/02/2008WO2008049874A1 Piperidyl-propane-thiol ccr3 modulators
05/02/2008WO2008049864A1 Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators
05/02/2008WO2008049856A2 Methods of treating pain using cdk inhibitors
05/02/2008WO2008049855A2 7-azaindole derivatives as c-met kinase inhibitors
05/02/2008WO2008049842A2 Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
05/02/2008WO2008049832A1 Furanone derivatives as cysteine protease inhibitors
05/02/2008WO2008049808A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives
05/02/2008WO2008049806A1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
05/02/2008WO2008049785A1 Ih channel inhibitors for the promotion of wakefulness
05/02/2008WO2008049747A1 Novel heteroaryl carboxamides
05/02/2008WO2008049657A2 Use of (meth)acrylate copolymers in slow-release pharmaceutical forms for reducing the influence of ethanol on active ingredient release
05/02/2008WO2008049644A1 Thymidine analogs for imaging
05/02/2008WO2008049605A1 Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents
05/02/2008WO2008049595A1 Trypsin-like serine protease inhibitors, and their preparation and use
05/02/2008WO2008049552A1 Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
05/02/2008WO2008049538A1 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
05/02/2008WO2008049516A2 Transdermal therapeutic system comprising norelgestromin for contraception and hormone replacement
05/02/2008WO2008049454A1 Virucidal composition
05/02/2008WO2008049424A2 Pharmaceutical composition for the treatment of allergic diseases
05/02/2008WO2008049402A2 Nail varnish remover for cosmetic and medical applications
05/02/2008WO2008049401A2 Nail varnish for cosmetic and medical applications
05/02/2008WO2008049330A1 Use of lipocalin-2 as a diagnostic marker and therapeutic target
05/02/2008WO2008049317A1 Biphenyl acetate, preparation and uses thereof
05/02/2008WO2008049265A1 Compositions for providing hepatoprotective effect
05/02/2008WO2008049232A1 Novel vitamin d2 yeast preparation, a method for producing the same, and the use thereof
05/02/2008WO2008049226A1 Inhibition of sox9 function fn the treatment of proteogl ycan-associated pathophysiological conditions
05/02/2008WO2008049198A1 Composition for weight loss comprising mulberry leaf, pinolenic acid and salacia oblonga extract
05/02/2008WO2008049196A1 Composition for improving blood cholesterol levels
05/02/2008WO2008049195A1 Acute and chronic heartburn composition and method
05/02/2008WO2008049194A1 Fat beta-oxidation enhancing and carbohydrate absorption inhibition supplement
05/02/2008WO2008049178A1 Stable and ready-to-use oil-in-water propofol microemulsion
05/02/2008WO2008049157A1 Combination therapy
05/02/2008WO2008033932A3 Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
05/02/2008WO2008032222A3 Treatment of vertigo with acetyl-l-leucine
05/02/2008WO2008031437A3 Treatment of asthma, eczema and/or allergy using antibiotics
05/02/2008WO2008030752A3 Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
05/02/2008WO2008030557A3 Compositions and methods for enhancing transport through mucus
05/02/2008WO2008030511A3 Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes
05/02/2008WO2008029168A3 Treatment of duchenne muscular dystrophy
05/02/2008WO2008028934A8 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof
05/02/2008WO2008028888A3 Use of cripto-1 or cripto-3 for the treatment of skeletal muscle wasting
05/02/2008WO2008026946A3 Compositions and methods for the treatment and prevention of neoplastic disorders
05/02/2008WO2008026765A3 Lyophilized preparation
05/02/2008WO2008024837A3 Rapid method for detecting mutated genes
05/02/2008WO2008024829A3 Radiohaloimatinibs and methods of their synthesis and use in pet imaging of cancers
05/02/2008WO2008023063A3 Treatment of cartilage disorders with fgf-18
05/02/2008WO2008019971A3 Arylpiperazine derivatives and uses thereof
05/02/2008WO2008019030A8 Modified azole compounds as antiinfective agents
05/02/2008WO2008011611A3 Compounds and compositions as itpkb inhibitors
05/02/2008WO2008010225A3 Enhancement of regulatory t cells' activity using statins
05/02/2008WO2008008882A3 Glucocorticoid receptor modulator and methods of use
05/02/2008WO2008006720A3 Crystalline nemorubicin hydrochloride
05/02/2008WO2008005565A3 Antiviral phosphinate compounds
05/02/2008WO2008003953A3 Therapeutic delivery of carbon monoxide
05/02/2008WO2008002946A3 Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist
05/02/2008WO2008002676A3 Biaryl compositions and methods for modulating a kinase cascade
05/02/2008WO2008002485A3 Increased amorphous stability of poorly water soluble drugs by nanosizing
05/02/2008WO2007150010A3 Cyclopropyl amine derivatives as histamin h3 receptor modulators
05/02/2008WO2007149782A3 Selective inhibitors for transferases
05/02/2008WO2007149505A3 Beta acid based protein kinase modulation cancer treatment
05/02/2008WO2007149503A3 Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
05/02/2008WO2007147899B1 Dha esters and use thereof in treatment and prevention of cardiovascular disease
05/02/2008WO2007146341A3 Amorphous and crystalline forms of pantoprazole magnesium salt
05/02/2008WO2007144621A3 Protection against and treatment of age related macular degeneration
05/02/2008WO2007144503A3 Novel process for preparing nitrones and n-hydroxylamines comprising at least one hydroxyl group, and products thus obtained
05/02/2008WO2007135293A3 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
05/02/2008WO2007131737A3 Medication against breast cancer and related diseases
05/02/2008WO2007128495A3 Solid pharmaceutical composition of gabapentin
05/02/2008WO2007119600A9 Carbazole compound
05/02/2008WO2007109160A3 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
05/02/2008WO2007109154A3 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
05/02/2008WO2007106264A3 Extended cycle multiphasic oral contraceptive method
1 ... 3278 3279 3280 3281 3282 3283 3284 3285 3286 3287 3288 3289 3290 3291 3292 3293 3294 3295 3296 3297 3298 ... 7860